Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Ryan S Cross"'
Autor:
Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes‐Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Publikováno v:
Clinical & Translational Immunology, Vol 12, Iss 3, Pp n/a-n/a (2023)
Abstract Objectives Glioblastoma is a highly aggressive and fatal brain malignancy, and effective targeted therapies are required. The combination of standard treatments including surgery, chemotherapy and radiotherapy is not curative. Chimeric antig
Externí odkaz:
https://doaj.org/article/daa67b3f5e504aa1970ae6379d7e3fcb
Autor:
Assaf Elazar, Nicholas J Chandler, Ashleigh S Davey, Jonathan Y Weinstein, Julie V Nguyen, Raphael Trenker, Ryan S Cross, Misty R Jenkins, Melissa J Call, Matthew E Call, Sarel J Fleishman
Publikováno v:
eLife, Vol 11 (2022)
De novo-designed receptor transmembrane domains (TMDs) present opportunities for precise control of cellular receptor functions. We developed a de novo design strategy for generating programmed membrane proteins (proMPs): single-pass α-helical TMDs
Externí odkaz:
https://doaj.org/article/4c88ae4a5ecb43b5a0ea6b73ec898c18
Autor:
Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes‐Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D’Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross, Misty R Jenkins
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 5, Pp n/a-n/a (2021)
Abstract Objectives The increasing success of Chimeric Antigen Receptor (CAR) T cell therapy in haematological malignancies is reinvigorating its application in many other cancer types and with renewed focus on its application to solid tumors. We pre
Externí odkaz:
https://doaj.org/article/bf76bd27261b474fb7938f17c07c871c
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e52351 (2012)
Heat induces Hsp70.1 (HSPA1) and Hsc70 (HSPA8) to form complex detergent insoluble cytoplasmic and nuclear structures that are distinct from the cytoskeleton and internal cell membranes. These novel structures have not been observed by earlier immuno
Externí odkaz:
https://doaj.org/article/fab2197f28084ae199163cf76363557e
Autor:
Paul J. Neeson, Phillip K. Darcy, Michael H. Kershaw, Joseph A. Trapani, David S. Ritchie, H. Miles Prince, Carmen S. Yong, Ryan S. Cross, Misty R. Jenkins, Alexander J. Davenport
Movie 2. CAR.OT-I cells co-cultured with MC57-OVA257 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8722c039ce594ac04ed58f03f4a15a52
https://doi.org/10.1158/2326-6066.22538524.v1
https://doi.org/10.1158/2326-6066.22538524.v1
Autor:
Paul J. Neeson, Phillip K. Darcy, Michael H. Kershaw, Joseph A. Trapani, David S. Ritchie, H. Miles Prince, Carmen S. Yong, Ryan S. Cross, Misty R. Jenkins, Alexander J. Davenport
Supplementary Figure 2. OVA257 peptide dose does not affect effector cell maturation status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5c2bdce5a2f63f4d7eaf5ea5be3a23
https://doi.org/10.1158/2326-6066.22538533
https://doi.org/10.1158/2326-6066.22538533
Autor:
Paul J. Neeson, Phillip K. Darcy, Michael H. Kershaw, Joseph A. Trapani, David S. Ritchie, H. Miles Prince, Carmen S. Yong, Ryan S. Cross, Misty R. Jenkins, Alexander J. Davenport
Movie 4. Serial killing of tumor targets by CAR.OT-I effector cells following engagement through the TCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3f8132136d64cc8d9bc2dff4656536
https://doi.org/10.1158/2326-6066.22538518.v1
https://doi.org/10.1158/2326-6066.22538518.v1
Autor:
Paul J. Neeson, Phillip K. Darcy, Michael H. Kershaw, Joseph A. Trapani, David S. Ritchie, H. Miles Prince, Carmen S. Yong, Ryan S. Cross, Misty R. Jenkins, Alexander J. Davenport
Movie 3. CAR.OT-I cells co-cultured with MC57-HER2 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f23e7e038a0d767b33a771ceb53dd92
https://doi.org/10.1158/2326-6066.22538521.v1
https://doi.org/10.1158/2326-6066.22538521.v1
Autor:
Paul J. Neeson, Phillip K. Darcy, Michael H. Kershaw, Joseph A. Trapani, David S. Ritchie, H. Miles Prince, Carmen S. Yong, Ryan S. Cross, Misty R. Jenkins, Alexander J. Davenport
Supplementary Figure 1. TCR activated OT-I and CAR. OT-I cells display similar expression levels of cytotoxic granules.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e971e7aae1cb642b53c88f88aebe2d9
https://doi.org/10.1158/2326-6066.22538536
https://doi.org/10.1158/2326-6066.22538536
Autor:
Paul J. Neeson, Phillip K. Darcy, Michael H. Kershaw, Joseph A. Trapani, David S. Ritchie, H. Miles Prince, Carmen S. Yong, Ryan S. Cross, Misty R. Jenkins, Alexander J. Davenport
Adoptive therapy with chimeric antigen receptor (CAR) T cells shows great promise clinically. However, there are important aspects of CAR-T-cell biology that have not been explored, particularly with respect to the kinetics of activation, immune syna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae2664785a285bb49ff5f9a4ce793a3b
https://doi.org/10.1158/2326-6066.c.6548806.v1
https://doi.org/10.1158/2326-6066.c.6548806.v1